A New Chapter in Global Cancer Treatment Begins in Sydney

In a quiet room inside Liverpool Hospital, southwest Sydney, a team of specialists gathered around a new suite of machines. Monitors glowed. A needle, just millimetres wide, moved with precision inside a patient’s body. The tumour, deep in the spine, began to freeze. By the time the procedure ended, the pain that had tormented Josephine Cordina for months had subsided.

Josephine, 64, had struggled with a nine-millimetre tumour in her spine. Sleep became a challenge. Over-the-counter medication wasn’t enough. Traditional surgery would have involved stabilising her spine with screws and weeks of recovery. Instead, she walked out of the hospital the next day, pain-free.

That procedure marked a first in Australia: MRI-guided cryoablation.

MRI-Guided Cryoablation: A Precise Shift in Oncology

The treatment can be performed under constant MRI guidance, with a gas-powered probe being positioned directly into an IC. Once in place, the procedure launches argon gas, which freezes the tumour below -40°C. In the field of radiology, this presents an `ice ball’ that can essentially do the lethal deed of killing the tumour cells. There remain the “weapons” and “soft procedures” of the hard-hitting, intractable “cold war”. Conversely, the prospective patient in MR-guided thermal ablation has no large cuts. No scalpels. No extended hospitalisation.

It’s minimally invasive, yet deeply targeted.

The advantage lies not just in precision but also in patient outcomes. Most patients return home within 24 hours. Post-procedure pain is minimal. The technology allows doctors to treat tumours in hard-to-reach or high-risk areas, such as near nerves or inside solid organs like the liver and kidneys.

Inside the IR-MACS Suite

Liverpool Hospital’s cryoablation procedures take place inside its newly commissioned IR-MACS suite — part of an $830 million infrastructure project designed to bring real-time image-guided interventions into one room. IR-MACS stands for Interventional Radiology, Magnetic Resonance Imaging, Angiography and Computed Tomography.

Integration of multiple imaging modalities enables clinicians to switch from diagnostic scans to needle placement and then on to treatment in the same session. That means no need for moving patients from room to room or waiting around.

This approach is rare — not just in Australia, but globally.

Numbers That Speak

According to NSW Health, Liverpool Hospital is the first in the country to combine MRI imaging with cryoablation technology in a public setting. The broader redevelopment of the hospital, valued at $830 million AUD (with additional allocations in recent state budgets), includes a cancer centre expected to open in 2027. The investment is designed to support the long-term application of image-guided cancer therapies.

Dr Glenn Schlaphoff, Director of Imaging at Liverpool Hospital, said the system enables high precision in delicate areas like the spine. It’s currently being used to treat select spinal, liver and kidney tumours — with further potential applications under study.

From a technical perspective, the MRI’s high-resolution imaging allows real-time visualisation of the tumour during freezing. Doctors can see the “ice ball” form and ensure it covers the entire lesion, avoiding damage to nearby healthy tissue.

A Global Lens on Cancer Care

Although the project began in Australia, it has far-reaching implications. As cancer rates globally continue to climb, especially with liver and renal tumours, the need for non-invasive, repeatable treatments has grown urgent. MRI-guided cryoablation suggests a way to take some of the pressure off of surgical wait lists, lower costs attributed to long recovery times, and lessen the financial burden on hospitals.

The public hospitals in Europe, Asia, and the Americas face similar challenges: increasing demands for oncology services, scarce surgical capacity, and high postoperative costs. Image-guided procedures like cryoablation show a roadmap toward scalable, less-resourced care models.

The Liverpool example signals that public hospitals—not just specialist centres—can lead the way in deploying advanced cancer care technologies. It presents an alternative to expensive, high-risk procedures while still achieving measurable patient outcomes.

Rethinking Public Hospital Branding

Liverpool Hospital’s advancement isn’t just a medical milestone. It’s also a branding statement.

As normally overshadowed by innovation narratives of private institutions in this domain, a public hospital takes the limelight, and this adds a new touch to health branding: that credibility and capacity do not always hinge on private funding or boutique infrastructure.

People will perceive a hospital that is being led by public funds as the main agency to be involved in all this now. Also, there is an IR-MACS setup, and in 2027, a cancer centre will open and show the way for others requiring a better place for healthcare within the global health map.

What these issues have proven to marketers is the strategy question of creating anticipation:

• Should communications run along with clinical milestones?
• Are the infrastructural capabilities of the hospital properly reflected?
• How do you tell success stories to global peers, funders, and talent?

Where Does This Fit Globally?

Non-invasive cancer treatments are gaining momentum across international health systems. The UK’s NHS, Germany’s public hospitals, and health providers in Singapore and Canada have begun pilot projects with similar technology, though few have fully integrated MRI-guided ablation into standard practice.

In countries with high public demand and constrained budgets, technologies like this could serve as force multipliers.

Still, access remains uneven. Advanced MRI units capable of guiding procedures in real time are not yet standard in most hospitals. Liverpool’s setup, combining cryoablation hardware with MRI and angiography in one suite, is rare even by global standards.

The adoption curve is steep. But the outcomes — shorter stays, lower pain, improved access — create a compelling case for accelerated investment.

Lessons for Healthcare Systems

The Liverpool model suggests several practical takeaways:

• Investment in hybrid imaging suites supports both treatment and diagnosis.
• MRI-guided procedures can reduce dependence on traditional operating theatres.
• Patient satisfaction and throughput improve when invasive steps are removed.
• Public hospitals can successfully implement high-precision technologies.

It also underlines a subtle truth: where and how treatment happens matters. Centralising imaging and treatment in one suite reduces friction, delays, and risk.

What Comes Next

Liverpool Hospital will continue expanding its image-guided treatment options. The new cancer centre, scheduled to open in 2027, will further embed cryoablation and other interventions into routine care.

Long-term studies will be essential. Comparative data on outcomes, re-treatment rates, and patient-reported experiences will help validate the model for other health systems.

The next step? Broader collaboration.

To scale MRI-guided cryoablation globally, hospitals will need shared protocols, cross-border training, and aligned purchasing strategies for hardware and consumables.

The technology is here. The model has been proven in practice.

It’s up to global health leaders to decide whether they’re ready to follow Liverpool’s lead.